Phase I and pharmacokinetic (PK) Study of CP-724,714, an oral human epidermal growth factor receptor-2 (HER-2) selective tyrosine kinase inhibitor

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3082-3082
Author(s):  
P. N. Munster ◽  
M. Mita ◽  
C. Britten ◽  
S. Minton ◽  
S. Moulder ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document